Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Dec 15, 2023; 15(12): 2101-2110
Published online Dec 15, 2023. doi: 10.4251/wjgo.v15.i12.2101
Published online Dec 15, 2023. doi: 10.4251/wjgo.v15.i12.2101
Table 1 An examination of the differences in the two groups’ baseline features
| Group | n | Sex (male/female, cases) | Age (yr, mean ± SD) | BMI (kg/m2, mean ± SD) | Surgical time, (min, mean ± SD) | ASA classification (I/II/III, cases) |
| Observation group | 51 | 33/18 | 49.58 ± 11.29 | 23.64 ± 1.54 | 216.15 ± 29.33 | 9/31/11 |
| Control group | 51 | 30/21 | 49.24 ± 11.58 | 23.28 ± 1.69 | 208.48 ± 31.67 | 12/33/6 |
| t/χ2 | 0.374 | 0.150 | 1.124 | 1.269 | 1.962 | |
| P value | 0.541 | 0.881 | 0.264 | 0.207 | 0.375 |
- Citation: Liu J, Tian JM, Liu GZ, Sun JN, Gao PF, Zhang YQ, Yue XQ. Application of remimazolam transversus abdominis plane block in gastrointestinal tumor surgery. World J Gastrointest Oncol 2023; 15(12): 2101-2110
- URL: https://www.wjgnet.com/1948-5204/full/v15/i12/2101.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i12.2101